PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Phenobarbital→

Phenobarbital PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
50-06-6
Molecular formula
C12H12N2O3
Molecular weight
232.23 g/mol
Drug class
Barbituratelong-acting anticonvulsant and sedative-hypnotic
Mechanism of action
Enhances GABAA receptor-mediated inhibitory neurotransmission by prolonging the duration of chloride-channel opening, hyperpolarising neurons and reducing neuronal excitability. At higher concentrations it can also directly activate GABAA receptors.
Indications / reported uses
  • Treatment of selected seizure disorders, including focal and generalised tonic-clonic seizures.
  • Sedative or anaesthetic adjunct use in selected clinical settings, depending on formulation and local authorisation.

Sources: https://www.ncbi.nlm.nih.gov/books/NBK532277/ · https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=phenobarbital

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Phenobarbital PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Phenobarbital Permitted Daily Exposure (PDE) report (the Phenobarbital PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Phenobarbital Occupational Exposure Limit (OEL) report (the Phenobarbital OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.